Nutrition Product List
Brand name Active ingredient Indication and usage
P L A CEN T A
Laennec inj. Human placenta hydrolysate 1 ml/ml Improvement of liver function in chronic liver diseases
Laennec Inj. Vial
VIT A MIN S
1. Prevention and treatment of vitamin C de ciency: scurvy, etc 2.V itamin C Demand inc rease: Pregnancy, Lactation, Execessive Physical labor Ascorbic acid 500 mg/ml 3. Suspected to be involved in metabolic disorders or vitamin de ciencies : 3-1Diso. rder of bone matrix formation and bony obstacle after bone fracture 3-2 Stains, freckles, hyperpigmentation after in ammation 3-3 Photodermatitis, etc Megagreen Inj.
1. Wernicke syndrome, beriberi, Heart disease 2. Suspected vitamin b1 de ciency or disturbances of metabolism 2-1 Neuralgia, muscular pain, arthralgia Fursultiamine hydrochloride 5.46 mg/ml 2-2 Peripheral neuritis, peripheral nerve paralysis 2-3 Myocardial matabolism disorder 2-4 Gastrointestinal disorder (ex. constipation) Fursultamin Inj. 2-5 Postoperative paralytic ileus
Prevention and treatment of vitamin D de ciency Cholecalciferol 5 mg/ml (200,000 IU) from Vitamin D-de cient aged person and adolescent
GCvitaD Inj.
1. Prevention and treatment of de ciency of D-Panthenol D-Panthenol 250mg/ml 2. Supply Panthotenic acid in case of increasing demand or insu cient intake of panthontenic acid from meal(wasting disease, hyperthyroid - ism, a pregnant woman, lactating women and so on)
1.Prevention and treatment of vitamin B6 de ciency disease 2. Vitamin B6 dependency Pyridoxine Hydrochloride 25 mg/ml 3. In cases vitamin de ciency or metabolic disorders: commissural cheilitis, acute and chronic eczema, seborrheic eczema peripheral neuritis, radiation sickness Megavitasix Inj.
Acute neuritis, multiple neuritis, sciatic neuralgia, rheumatoid neuralgia, Hydroxocobalamin 2.5 mg/ml shoulder-arm-neck syndrome, radiculopathy, scapula periarthritis, Neural - gia by cancer and trauma, Neuralgia by herpes zoster and migraine GCvitaonetwo Inj. Brand name Active ingredient Indication and usage
ANT I - O XID ANT S
Glutathion (reduced) 600 mg / 1200 mg Prevention of cisplatin(platinum)-induced neuropathy
GCtathione Inj. 600mg / 1200mg
1. Increase demand of thiotic acid (Execessive physical labor) Thioctic acid 5 mg/ml 2. Leigh syndrome (subacute necrotizing encephalitis) 3. Toxicity (streptomycin, Kanamycin) and labyrinthine deafness GCthioctic acid Inj.
1. Di cult Sputum expectoration from bronchial diseases with thick dense sputum ; acute bronchitis, chronic bronchitis, asthmatic bronchitis, bron- Acetylcysteine 100 mg/ml chial asthma, laryngopharyngitis, sinusitis, cystic brosis, Postoperative pulmonary commplication 2. Detoxication of paracetamol(acetaminophen) intoxication GCNAC Inj.
MINE R A L S
1. Convulsion 2. Eclampsia Magnesium sulfate 10% 0.1 g/ml 3. Supply the electrolyte (hypomagnesemia) Meganesium 4. Uterus rigidity (parturifacient) 10% Inj.
Zinc sulfate hydrate 22.0 mg/ml (Zn 5.0 mg/ml) Cupric sulfate hydrate 3.93 mg/ml (Cu 1.0 mg/ml) Use as an additive for Total Parenteral Nutrition (TPN) Manganese sulfate hydrate 1.54 mg/ml (Mn 0.5 mg/ml) Chromic choride hydrate 0.051 mg/ml GCtrace Inj. (Cr 0.01 mg/ml)
Zinc Sulfate Hydrate 4.4 mg/ml Zinc level restoration during Total Parenteral Nutrition (TPN) (Zn 1 mg/ml)
GCzinc Inj.
Gluconate calcium hydrate 104.2 mg/ml Tetany due to hypocalcemia or assocated symptoms (urticaria, hyper- (Ca 9.765 mg/ml) kalemia, magnesium intoxication) GCcalcium gluconate Inj. Brand name Active ingredient Indication and usage
MISCEL L ANEO U S
A secondary symptom and denatured or degenerative organic psychogenic syndrome due to cerebral vascular defect (decreased memory, confusion, orientation and sensory disorder due to decreased Choline alfoscerate 0.25 g/ml drive and spontaneity, decreased concentration), Change of emotion and behavior, mood irritability, stimulation hypersensitiveness,Apathy, senile pseudo-depression GCcholine Inj.
1. Primary and secondary carnitine de ciency 2. Myocardial metabolic disorder by ischemic heart disease: L-carnitine 0.2 g/ml angina, acute myocardial infarction 3. The prevention and treatment of carnitine de ciency in patients with end stage renal disease who are undergoing dialysis GCcartin Inj.
Sodium bicarbonate 84mg/ml Dr. Paul Lohmann GmBH (Germany)
GCsodium bicarbonate Inj.
1. Urticaria In 20 ml 2. Ezema Ammonium glycyrrhizinate 53 mg 3. Allergic dermatitis Glycine 400 mg 4. Adjuvant therapy for drug addiction L-cysteine hydrochloride 20 mg 5. Improvement liver function in chronic liver disease Hishiphagen-C Inj.
SOL UTION
Sodium 1. Supply of water and electrolyte de ciency chloride Sodium chloride 0.9% (sodium de cit, chlorine de cit) 0.9% Kit 2. Dissolution diluent of injections
5% 1. Dehydration, specially water supply of water de cit. Dextrose 5% Dextrose 2. Dissolution diluent of injections kit